Cipla share price is Down ▼-1.13% on 02-Aug-2024

Cipla share price is Down ▼-1.13% on 02-Aug-2024. | 1.35m shares traded.
Its Current Matket Price is Rs 1528.8 and Market Cap is approximately : 1.2 Lack Crores.
The stock is up ▲ 1.9% in 7 days,
up ▲ 2.7% in 1 month
and up ▲ 5.3% in 2 months.
Please click image for Latest Daily data.
Cipla Results June 2024 (Standalone_YoY) revenue elevated to 4501 crores up 4% in June 2024 quarter, compared with 4318 crores in June 2023. Its Net profit is 1056 crores up 17% in June 2024 quarter, compared with 895 crores in last year same quarter. Please click Image for Daily Data and Results of the stock.
* Data updated everyday at 7pm. Only Data. Not Buy or Sell advice.

Click Image for Data | Scroll down for Comments

About Cipla :

Founded: 1935, Mumbai
Founder: Khwaja Abdul Hamied
Headquarters: Mumbai
Number of employees: 32,323 (2023)
Revenue: 22,753 crores INR (US$2.8 billion, FY23)
Subsidiaries: Cipla USA Inc., Cipla (EU) Limited,

Cipla Limited is an Indian pharmaceutical company that was founded in 1935 in Mumbai. It is the third largest drug producer in India and has 47 manufacturing locations globally. Cipla’s products include:
Active pharmaceutical ingredients
Pharmaceutical and personal care products
Antiretroviral drugs
Escitalopram oxalate
Lamivudine
Fluticasone propionate

Cipla’s products are used to treat a variety of medical conditions, including: Respiratory disease, Cardiovascular disease, Arthritis, Diabetes, Depression.

Cipla subsidiaries include Cipla USA Inc. and Cipla Kenya Limited.
—————————————————-
* About company information is from various sources on the internet ( March 2024 ).
Please verify the official website of company for the latest updated information.
—————————————————-

Please visit